Table 1.
Patient data with NMT positivity for peripheral blood mononuclear cells.
| Patient | Age | Sex | Diagnosis | Staging (TNM) | NMT +ve Cells | Intensity |
| 1 | 74 | M | Adenocarcinoma of the traverse colon | pT3b, pN0, pMx | > 80% | Strong |
| 2 | 73 | F | Adenocarcinoma of the cecum | pT3a, pN0, pMx | > 80% | Moderate |
| 3 | 74 | F | Adenocarcinoma of the cecum | pT3a, pN0, pMx | 30–50% | Moderate |
| 4 | 66 | F | Adenocarcinoma of the ascending colon | pT3, pN0, pM0 | 30–50% | Weak |
| 5 | 66 | M | Adenocarcinoma of the ascending colon | pT3a, pN0, pMx, pV2 | 30–50% | Moderate |
| 6 | 88 | M | Adenocarcinoma of the rectum | pT2. pN0, pMx | 50–75% | Moderate |
| 7 | 75 | M | Invasive mucinous adenocarcinoma | pT4b, pN2, pMx | > 75% | Moderate |
| 8 | 83 | M | Adenocarcinoma of the rectum | pT3c/d, pN2 | > 75% | Strong |
| Control | ||||||
| 1 | 45 | M | < 5% | Weak | ||
| 2 | 34 | F | < 5% | Negative | ||
| 3 | 23 | F | 10–15% | Weak | ||
| 4 | 59 | M | 10–15% | Moderate | ||
| 5 | 64 | M | > 80% | Moderate* |
* This was submitted as a control subject and displayed more than 80% positive cells. Later on it was found that the patient had a history of colon cancer.